0001192482-19-000488.txt : 20191209
0001192482-19-000488.hdr.sgml : 20191209
20191209182700
ACCESSION NUMBER: 0001192482-19-000488
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191209
DATE AS OF CHANGE: 20191209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENWOOD GERALDINE
CENTRAL INDEX KEY: 0001236451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 191276249
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-12-05
0001588972
Recro Pharma, Inc.
REPH
0001236451
HENWOOD GERALDINE
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN,
PA
19355
1
1
0
0
President and CEO
Common Stock
2019-12-05
4
A
0
93550
0
A
246691
D
Common Stock
50000
I
By spouse
These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued employment with the Company.
The number of shares in Column 5 reflects a bona fide gift of 45,000 shares on November 27, 2018 by the reporting person as reported on the Form 5 filed by the reporting person on February 14, 2019.
/s/ Ryan Lake, Attorney-in-fact
2019-12-09